Association of Abnormal Plasma Bilirubin With Aggressive Hepatocellular Carcinoma Phenotype-Reference-Cited by-同舟云学术

Association of Abnormal Plasma Bilirubin With Aggressive Hepatocellular Carcinoma Phenotype

Published:2014-04 Issue:2 Volume:41 Page:252-258
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Carr Brian I.,Guerra Vito,Giannini Edoardo G.,Farinati Fabio,Ciccarese Francesca,Ludovico Rapaccini Gian,Di Marco Maria,Benvegnù Luisa,Zoli Marco,Borzio Franco,Caturelli Eugenio,Chiaramonte Maria,Trevisani Franco

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference20 articles.

1. Natural history of hepatocellular carcinoma and prognosis in relation to treatment;Okuda;Cancer,1985

2. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients;Hepatology,1998

3. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet;Semin Liver Dis,1999

4. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre;Grieco;Gut,2005

5. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients;Tateishi;Gut,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-energy computed tomography iodine quantification combined with laboratory data for predicting microvascular invasion in hepatocellular carcinoma: a two-centre study;British Journal of Radiology;2024-06-13

2. Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma;Journal of Biochemical and Molecular Toxicology;2024-05-27

3. Targeting the NF-κB p65/Bcl-2 signaling pathway in hepatic cellular carcinoma using radiation assisted synthesis of zinc nanoparticles coated with naturally isolated gallic acid;Biomedicine & Pharmacotherapy;2024-03

4. LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study;BMC Cancer;2024-03-01

5. The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors;Hepatology International;2023-12-01